Drug profile · INN
vincristine
DBL VINCRISTINE SULFATE
vincristine (DBL VINCRISTINE SULFATE) is a tubulin inhibitor. Associated with Pfizer Australia Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 2
Pipeline programs 38
News articles 0
Drug details — vincristine
- Class
- —
- Route
- —
- Patents
- 2
- Programs
- 38
- Data quality
- 0.81
Quick answer
vincristine (DBL VINCRISTINE SULFATE) is a tubulin inhibitor. Associated with Pfizer Australia Pty Ltd.
Key facts
INN vincristine
Brand DBL VINCRISTINE SULFATE
Mechanism Tubulin inhibitor
Originator Pfizer Australia Pty Ltd
Mechanism of action
Tubulin inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related patents
Frequently asked questions
What is vincristine?
vincristine (DBL VINCRISTINE SULFATE) is a tubulin inhibitor. Associated with Pfizer Australia Pty Ltd.
What is the brand name for vincristine?
DBL VINCRISTINE SULFATE is a marketed brand name for vincristine. Check FDA Drugs@FDA for the current US label holder and prescribing information.